China

Drugmaker Regeneron working with U.S. HHS to develop coronavirus treatment
Reuters
Tue, 02/4/20 - 10:17 am
Regeneron
Wuhan Coronavirus
HHS
China
Here's Why Inovio Pharmaceuticals and Vir Biotechnology Shares Have Fallen Today
Motley Fool
Tue, 02/4/20 - 12:00 am
Inovio
Vir Biotechnology
Gilead Sciences
Wuhan Coronavirus
China
remdesivir
Gilead climbs as coronavirus drug shows efficacy, starts trial
Fierce Biotech
Mon, 02/3/20 - 11:00 am
Gilead Sciences
remdesivir
China
Wuhan Coronavirus
3 Big Drugmakers Are Taking On the Coronavirus
Motley Fool
Mon, 02/3/20 - 10:32 am
Gilead Sciences
Moderna Therapeutics
Roche
Wuhan Coronavirus
China
Pandemic fears force Chinese biotech to postpone Hong Kong IPO meetings — Bloomberg
Endpoints
Mon, 02/3/20 - 10:30 am
China
Hong Kong
IPOs
Wuhan Coronavirus
InnoCare Pharma
Has pharma been too slow to respond to coronavirus?
Pharmaforum
Mon, 02/3/20 - 10:28 am
China
Wuhan Coronavirus
JNJ
CEPI
Inovio
Moderna Therapeutics
Vas Narasimhan wants Novartis to have a big focus on China. Here’s what that looks like
Endpoints
Thu, 01/30/20 - 10:49 am
Novartis
China
Pharma CEOs
Vas Narasimhan
Pfizer is bulking up its Mylan-Upjohn spinoff but investors may not reap rewards: analysts
Fierce Pharma
Wed, 01/29/20 - 11:57 pm
Pfizer
Mylan
Upjohn
Viatris
China
AbbVie's HIV Drug Aluvia Seen as Potential Treatment for Coronavirus
BioSpace
Mon, 01/27/20 - 10:51 pm
AbbVie
Aluvia
Wuhan Coronavirus
China
‘The time to worry is now’: The coronavirus in China could threaten pharma’s ingredient sourcing
Stat
Mon, 01/27/20 - 10:36 am
China
supply chain
active pharmaceutical ingredients
Wuhan Coronavirus
Amgen wades deeper into Asia with full control of an Astellas Japanese JV
Fierce Pharma
Thu, 01/23/20 - 12:12 pm
Amgen
Astellas
Japan
BeiGene
China
Roche cracks China's ADC market open as Kadcyla scores its first breast cancer OK in the country
Endpoints
Thu, 01/23/20 - 12:11 pm
Roche
Kadcyla
China
breast cancer
antibody-drug conjugate
Wuhan Coronavirus Hits the U.S. And Vaccine Stock Soars
Motley Fool
Tue, 01/21/20 - 11:43 pm
Wuhan Coronavirus
China
CDC
vaccines
Novavax
Drugmakers slash prices to be eligible for China’s bulk-buy program
CNBC
Mon, 01/20/20 - 10:12 pm
China
off-patent
bulk-buy
After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
Fierce Biotech
Fri, 01/17/20 - 12:08 pm
IPOs
China
NASDAQ
I-Mab Biopharma
autoimmune disease
cancer
Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar
BioSpace
Thu, 01/16/20 - 11:14 pm
China
Innovent Biologics
Coherus Biosciences
biosimilars
Avastin
China’s CF PharmTech Raises $90M to Advance Respiratory Drug Development
Xconomy
Mon, 01/6/20 - 10:28 am
China
CF PharmTech
respiratory disease
drug development
AstraZeneca kicks off 2020 with double win in US and China
Pharmaforum
Mon, 01/6/20 - 10:23 am
AstraZeneca
FDA
Farxiga
heart failure
China
Lokelma
hyperkalemia
Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China
Fierce Pharma
Sun, 01/5/20 - 07:07 pm
Pfizer
Merck
Prevnar 13
Gardasil
vaccines
China
Walvax
Amgen to Sell Cancer Drugs in China Thanks to $2.7B Deal with BeiGene
Xtalks
Fri, 01/3/20 - 10:51 pm
Amgen
BeiGene
oncology
China

Pages